Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 172

1.

FOLFOXIRI Plus Panitumumab As First-Line Treatment of RAS Wild-Type Metastatic Colorectal Cancer: The Randomized, Open-Label, Phase II VOLFI Study (AIO KRK0109).

Modest DP, Martens UM, Riera-Knorrenschild J, Greeve J, Florschütz A, Wessendorf S, Ettrich T, Kanzler S, Nörenberg D, Ricke J, Seidensticker M, Held S, Buechner-Steudel P, Atzpodien J, Heinemann V, Seufferlein T, Tannapfel A, Reinacher-Schick AC, Geissler M.

J Clin Oncol. 2019 Oct 14:JCO1901340. doi: 10.1200/JCO.19.01340. [Epub ahead of print]

PMID:
31609637
2.

Relationship Between Tumor Response and Tumor-Related Symptoms in RAS Wild-Type Metastatic Colorectal Cancer: Retrospective Analyses From 3 Panitumumab Trials.

Taieb J, Geissler M, Rivera F, Karthaus M, Wilson R, Loupakis F, Price T, Tracy M, Burdon P, Peeters M.

Clin Colorectal Cancer. 2019 Jul 29. pii: S1533-0028(19)30162-8. doi: 10.1016/j.clcc.2019.07.009. [Epub ahead of print]

3.

Evaluation of surfactin synthesis in a genome reduced Bacillus subtilis strain.

Geissler M, Kühle I, Morabbi Heravi K, Altenbuchner J, Henkel M, Hausmann R.

AMB Express. 2019 Jun 12;9(1):84. doi: 10.1186/s13568-019-0806-5.

4.

Surfactin and fengycin contribute to the protection of a Bacillus subtilis strain against grape downy mildew by both direct effect and defence stimulation.

Li Y, Héloir MC, Zhang X, Geissler M, Trouvelot S, Jacquens L, Henkel M, Su X, Fang X, Wang Q, Adrian M.

Mol Plant Pathol. 2019 Aug;20(8):1037-1050. doi: 10.1111/mpp.12809. Epub 2019 May 18.

5.

Extraction of nucleic acids from blood: unveiling the potential of active pneumatic pumping in centrifugal microfluidics for integration and automation of sample preparation processes.

Brassard D, Geissler M, Descarreaux M, Tremblay D, Daoud J, Clime L, Mounier M, Charlebois D, Veres T.

Lab Chip. 2019 Jun 7;19(11):1941-1952. doi: 10.1039/c9lc00276f. Epub 2019 Apr 18.

PMID:
30997461
6.

A Blood-Based Multi Marker Assay Supports the Differential Diagnosis of Early-Stage Pancreatic Cancer.

Berger AW, Schwerdel D, Reinacher-Schick A, Uhl W, Algül H, Friess H, Janssen KP, König A, Ghadimi M, Gallmeier E, Bartsch DK, Geissler M, Staib L, Tannapfel A, Kleger A, Beutel A, Schulte LA, Kornmann M, Ettrich TJ, Seufferlein T.

Theranostics. 2019 Feb 12;9(5):1280-1287. doi: 10.7150/thno.29247. eCollection 2019.

7.

Evaluating the Use of Edge Detection in Extracting Feature Size from Scanning Electrochemical Microscopy Images.

Stephens LI, Payne NA, Skaanvik SA, Polcari D, Geissler M, Mauzeroll J.

Anal Chem. 2019 Mar 19;91(6):3944-3950. doi: 10.1021/acs.analchem.8b05011. Epub 2019 Feb 28.

PMID:
30777431
8.

Phase Ib evaluation of a self-adjuvanted protamine formulated mRNA-based active cancer immunotherapy, BI1361849 (CV9202), combined with local radiation treatment in patients with stage IV non-small cell lung cancer.

Papachristofilou A, Hipp MM, Klinkhardt U, Früh M, Sebastian M, Weiss C, Pless M, Cathomas R, Hilbe W, Pall G, Wehler T, Alt J, Bischoff H, Geißler M, Griesinger F, Kallen KJ, Fotin-Mleczek M, Schröder A, Scheel B, Muth A, Seibel T, Stosnach C, Doener F, Hong HS, Koch SD, Gnad-Vogt U, Zippelius A.

J Immunother Cancer. 2019 Feb 8;7(1):38. doi: 10.1186/s40425-019-0520-5.

9.

Neoadjuvant plus adjuvant or only adjuvant nab-paclitaxel plus gemcitabine for resectable pancreatic cancer - the NEONAX trial (AIO-PAK-0313), a prospective, randomized, controlled, phase II study of the AIO pancreatic cancer group.

Ettrich TJ, Berger AW, Perkhofer L, Daum S, König A, Dickhut A, Wittel U, Wille K, Geissler M, Algül H, Gallmeier E, Atzpodien J, Kornmann M, Muche R, Prasnikar N, Tannapfel A, Reinacher-Schick A, Uhl W, Seufferlein T.

BMC Cancer. 2018 Dec 29;18(1):1298. doi: 10.1186/s12885-018-5183-y.

10.

Erlotinib.

Steins M, Thomas M, Geißler M.

Recent Results Cancer Res. 2018;211:1-17. doi: 10.1007/978-3-319-91442-8_1. Review.

PMID:
30069756
11.

Relationships between tumour response and primary tumour location, and predictors of long-term survival, in patients with RAS wild-type metastatic colorectal cancer receiving first-line panitumumab therapy: retrospective analyses of the PRIME and PEAK clinical trials.

Peeters M, Price T, Taieb J, Geissler M, Rivera F, Canon JL, Pentheroudakis G, Koukakis R, Burdon P, Siena S.

Br J Cancer. 2018 Aug;119(3):303-312. doi: 10.1038/s41416-018-0165-z. Epub 2018 Jul 17.

12.

Subcellular localization defines modification and production of Δ9-tetrahydrocannabinolic acid synthase in transiently transformed Nicotiana benthamiana.

Geissler M, Volk J, Stehle F, Kayser O, Warzecha H.

Biotechnol Lett. 2018 Jun;40(6):981-987. doi: 10.1007/s10529-018-2545-0. Epub 2018 Apr 4.

PMID:
29619743
13.

Author Correction: Exploratory analyses assessing the impact of early tumour shrinkage and depth of response on survival outcomes in patients with RAS wild-type metastatic colorectal cancer receiving treatment in three randomised panitumumab trials.

Taieb J, Rivera F, Siena S, Karthaus M, Valladares-Ayerbes M, Gallego J, Geissler M, Koukakis R, Demonty G, Peeters M.

J Cancer Res Clin Oncol. 2018 Apr;144(4):795-797. doi: 10.1007/s00432-018-2591-y.

PMID:
29450632
14.

PICCA study: panitumumab in combination with cisplatin/gemcitabine chemotherapy in KRAS wild-type patients with biliary cancer-a randomised biomarker-driven clinical phase II AIO study.

Vogel A, Kasper S, Bitzer M, Block A, Sinn M, Schulze-Bergkamen H, Moehler M, Pfarr N, Endris V, Goeppert B, Merx K, Schnoy E, Siveke JT, Michl P, Waldschmidt D, Kuhlmann J, Geissler M, Kahl C, Evenkamp R, Schmidt T, Kuhlmann A, Weichert W, Kubicka S.

Eur J Cancer. 2018 Mar;92:11-19. doi: 10.1016/j.ejca.2017.12.028. Epub 2018 Feb 3.

PMID:
29413685
15.

[From Molecuar to Natural Medicine].

Allgaier HP, Arnold C, Baumert TF, Becker G, Geißler M, Hafkemeyer P, Harder J, Heim MH, Huber R, Kern WV, Mohr L, Moradpour D, Offensperger S, Offensperger WB, Spangenberg HC, Thimme R, Walter E, von Weizsäcker F.

Dtsch Med Wochenschr. 2018 Jan;143(1):40-45. doi: 10.1055/s-0043-123263. Epub 2018 Jan 9. German. No abstract available.

PMID:
29316584
16.

Exploratory analyses assessing the impact of early tumour shrinkage and depth of response on survival outcomes in patients with RAS wild-type metastatic colorectal cancer receiving treatment in three randomised panitumumab trials.

Taieb J, Rivera F, Siena S, Karthaus M, Valladares-Ayerbes M, Gallego J, Geissler M, Koukakis R, Demonty G, Peeters M.

J Cancer Res Clin Oncol. 2018 Feb;144(2):321-335. doi: 10.1007/s00432-017-2534-z. Epub 2017 Oct 28. Erratum in: J Cancer Res Clin Oncol. 2018 Feb 15;:.

17.

Panitumumab in Combination With Preoperative Radiation Therapy in Patients With Locally Advanced RAS Wild-type Rectal Cancer: Results of the Multicenter Explorative Single-Arm Phase 2 Study NEORIT.

Merx K, Martens UM, Kripp M, Hoehler T, Geissler M, Gaiser T, Mai S, Kienle P, Belle S, Plöger C, Hieber U, Wenz F, Post S, Hofheinz RD.

Int J Radiat Oncol Biol Phys. 2017 Nov 15;99(4):867-875. doi: 10.1016/j.ijrobp.2017.06.2460. Epub 2017 Jun 28.

PMID:
28870789
18.

Food-induced anaphylaxis and cofactors - data from the anaphylaxis registry.

Worm M, Scherer K, Köhli-Wiesner A, Ruëff F, Mahler V, Lange L, Treudler R, Rietschel E, Szepfalusi Z, Lang R, Rabe U, Reese T, Schwerk N, Beyer K, Hompes S, Bircher A, Przybilla B, Hawranek T, Hansen G, Friedrichs F, Merk H, Tenbrock K, Lehmann S, Gerstlauer M, Kleine-Tebbe J, Niggemann B, Dickel H, Bücheler M, Bieber T, Hanfland J, Schmitt-Grohe S, Vlajnic D, Heckmann V, Nemat K, Schäkel K, Nordwig A, Schuster A, Schweitzer-Krantz S, Hillen U, Kopp M, Szliska C, Klinge J, Neustädter I, Fuchs T, Bruns R, Marsch C, Kreft B, Coors E, Rebien W, Wedi B, Pföhler C, Rett M, Henzgen M, Vöhringer P, Fölster-Holst R, Hunzelmann N, Siebenhaar G, Nestoris S, Schirpke C, Grabbe J, Stichtenoth G, Ring J, Brockow K, Brehler R, Yildiz I, Volkmuth S, Geißler M, Polz M, Riffelmann F, Thies S, Lepp U, Rabe U, Rebmann H, Spindler T, Klimek L, Pfaar O, Brosi W, Aberer W, Varga E, Reider N, Huttegger I, Kinaciyan T, Hoffmann-Sommergruber K, Eng P, Helbling A, Eigenmann P, Guggenheim R, Schmid-Grendelmeier P.

Allergol Select. 2017 Aug 4;1(1):21-27. doi: 10.5414/ALX01401E. eCollection 2017.

19.

Determination of the Relationship between Expression and Functional Activity of Multidrug Resistance-Associated Protein 1 using Scanning Electrochemical Microscopy.

Polcari D, Hernández-Castro JA, Li K, Geissler M, Mauzeroll J.

Anal Chem. 2017 Sep 5;89(17):8988-8994. doi: 10.1021/acs.analchem.7b01601. Epub 2017 Aug 9.

PMID:
28730808
20.

Production of microbial biosurfactants: Status quo of rhamnolipid and surfactin towards large-scale production.

Henkel M, Geissler M, Weggenmann F, Hausmann R.

Biotechnol J. 2017 Jul;12(7). doi: 10.1002/biot.201600561. Epub 2017 May 23. Review.

PMID:
28544628
21.

Comparative composition, diversity, and abundance of oligosaccharides in early lactation milk from commercial dairy and beef cows.

Sischo WM, Short DM, Geissler M, Bunyatratchata A, Barile D.

J Dairy Sci. 2017 May;100(5):3883-3892. doi: 10.3168/jds.2016-12388. Epub 2017 Mar 17.

22.

ATM mutations and E-cadherin expression define sensitivity to EGFR-targeted therapy in colorectal cancer.

Geißler AL, Geißler M, Kottmann D, Lutz L, Fichter CD, Fritsch R, Weddeling B, Makowiec F, Werner M, Lassmann S.

Oncotarget. 2017 Mar 7;8(10):17164-17190. doi: 10.18632/oncotarget.15211.

23.

High-performance thin-layer chromatography (HPTLC) for the simultaneous quantification of the cyclic lipopeptides Surfactin, Iturin A and Fengycin in culture samples of Bacillus species.

Geissler M, Oellig C, Moss K, Schwack W, Henkel M, Hausmann R.

J Chromatogr B Analyt Technol Biomed Life Sci. 2017 Feb 15;1044-1045:214-224. doi: 10.1016/j.jchromb.2016.11.013. Epub 2016 Nov 10.

PMID:
28153674
24.

The Indirect Neuron-astrocyte Coculture Assay: An In Vitro Set-up for the Detailed Investigation of Neuron-glia Interactions.

Gottschling C, Dzyubenko E, Geissler M, Faissner A.

J Vis Exp. 2016 Nov 14;(117). doi: 10.3791/54757.

25.

Impact of SPARC expression on outcome in patients with advanced pancreatic cancer not receiving nab-paclitaxel: a pooled analysis from prospective clinical and translational trials.

Ormanns S, Haas M, Baechmann S, Altendorf-Hofmann A, Remold A, Quietzsch D, Clemens MR, Bentz M, Geissler M, Lambertz H, Kruger S, Kirchner T, Heinemann V, Boeck S.

Br J Cancer. 2016 Dec 6;115(12):1520-1529. doi: 10.1038/bjc.2016.355. Epub 2016 Nov 1.

26.

First and second generation antipsychotics differentially affect structural and functional properties of rat hippocampal neuron synapses.

Gottschling C, Geissler M, Springer G, Wolf R, Juckel G, Faissner A.

Neuroscience. 2016 Nov 19;337:117-130. doi: 10.1016/j.neuroscience.2016.08.055. Epub 2016 Sep 8.

PMID:
27615033
27.

Tumor promotion and inhibition by phenobarbital in livers of conditional Apc-deficient mice.

Braeuning A, Gavrilov A, Geissler M, Wenz C, Colnot S, Templin MF, Metzger U, Römer M, Zell A, Schwarz M.

Arch Toxicol. 2016 Jun;90(6):1481-94. doi: 10.1007/s00204-016-1667-1. Epub 2016 Feb 2.

PMID:
26838046
28.

DocOx (AIO-PK0106): a phase II trial of docetaxel and oxaliplatin as a second line systemic therapy in patients with advanced pancreatic ductal adenocarcinoma.

Ettrich TJ, Perkhofer L, von Wichert G, Gress TM, Michl P, Hebart HF, Büchner-Steudel P, Geissler M, Muche R, Danner B, Kächele V, Berger AW, Güthle M, Seufferlein T.

BMC Cancer. 2016 Jan 15;16:21. doi: 10.1186/s12885-016-2052-4.

29.

A novel cinnamyl alcohol dehydrogenase (CAD)-like reductase contributes to the structural diversity of monoterpenoid indole alkaloids in Rauvolfia.

Geissler M, Burghard M, Volk J, Staniek A, Warzecha H.

Planta. 2016 Mar;243(3):813-24. doi: 10.1007/s00425-015-2446-6. Epub 2015 Dec 29.

PMID:
26715562
30.

Microfluidic Integration of a Cloth-Based Hybridization Array System (CHAS) for Rapid, Colorimetric Detection of Enterohemorrhagic Escherichia coli (EHEC) Using an Articulated, Centrifugal Platform.

Geissler M, Clime L, Hoa XD, Morton KJ, Hébert H, Poncelet L, Mounier M, Deschênes M, Gauthier ME, Huszczynski G, Corneau N, Blais BW, Veres T.

Anal Chem. 2015 Oct 20;87(20):10565-72. doi: 10.1021/acs.analchem.5b03085. Epub 2015 Oct 7.

PMID:
26416260
31.

Impact of hand-foot skin reaction on treatment outcome in patients receiving capecitabine plus erlotinib for advanced pancreatic cancer: a subgroup analysis from AIO-PK0104.

Kruger S, Boeck S, Heinemann V, Laubender RP, Vehling-Kaiser U, Waldschmidt D, Kettner E, Märten A, Winkelmann C, Klein S, Kojouharoff G, Gauler TC, Fischer von Weikersthal L, Clemens MR, Geissler M, Greten TF, Hegewisch-Becker S, Modest DP, Stintzing S, Haas M.

Acta Oncol. 2015 Jul;54(7):993-1000. doi: 10.3109/0284186X.2015.1034877. Epub 2015 Apr 30.

PMID:
25924969
32.

Active pneumatic control of centrifugal microfluidic flows for lab-on-a-chip applications.

Clime L, Brassard D, Geissler M, Veres T.

Lab Chip. 2015 Jun 7;15(11):2400-11. doi: 10.1039/c4lc01490a.

PMID:
25860103
33.

Microfluidic filtration and extraction of pathogens from food samples by hydrodynamic focusing and inertial lateral migration.

Clime L, Hoa XD, Corneau N, Morton KJ, Luebbert C, Mounier M, Brassard D, Geissler M, Bidawid S, Farber J, Veres T.

Biomed Microdevices. 2015 Feb;17(1):17. doi: 10.1007/s10544-014-9905-x.

PMID:
25653055
34.

NeoFLOT: Multicenter phase II study of perioperative chemotherapy in resectable adenocarcinoma of the gastroesophageal junction or gastric adenocarcinoma-Very good response predominantly in patients with intestinal type tumors.

Schulz C, Kullmann F, Kunzmann V, Fuchs M, Geissler M, Vehling-Kaiser U, Stauder H, Wein A, Al-Batran SE, Kubin T, Schäfer C, Stintzing S, Giessen C, Modest DP, Ridwelski K, Heinemann V.

Int J Cancer. 2015 Aug 1;137(3):678-85. doi: 10.1002/ijc.29403. Epub 2015 Feb 25.

35.

Gemcitabine plus sorafenib versus gemcitabine alone in advanced biliary tract cancer: a double-blind placebo-controlled multicentre phase II AIO study with biomarker and serum programme.

Moehler M, Maderer A, Schimanski C, Kanzler S, Denzer U, Kolligs FT, Ebert MP, Distelrath A, Geissler M, Trojan J, Schütz M, Berie L, Sauvigny C, Lammert F, Lohse A, Dollinger MM, Lindig U, Duerr EM, Lubomierski N, Zimmermann S, Wachtlin D, Kaiser AK, Schadmand-Fischer S, Galle PR, Woerns M; Working Group of Internal Oncology.

Eur J Cancer. 2014 Dec;50(18):3125-35. doi: 10.1016/j.ejca.2014.09.013. Epub 2014 Oct 15.

36.

pERK, pAKT and p53 as tissue biomarkers in erlotinib-treated patients with advanced pancreatic cancer: a translational subgroup analysis from AIO-PK0104.

Ormanns S, Siveke JT, Heinemann V, Haas M, Sipos B, Schlitter AM, Esposito I, Jung A, Laubender RP, Kruger S, Vehling-Kaiser U, Winkelmann C, Fischer von Weikersthal L, Clemens MR, Gauler TC, Märten A, Geissler M, Greten TF, Kirchner T, Boeck S.

BMC Cancer. 2014 Aug 28;14:624. doi: 10.1186/1471-2407-14-624.

37.

Integrated air stream micromixer for performing bioanalytical assays on a plastic chip.

Geissler M, Li K, Zhang X, Clime L, Robideau GP, Bilodeau GJ, Veres T.

Lab Chip. 2014 Oct 7;14(19):3750-61. doi: 10.1039/c4lc00769g.

PMID:
25091476
38.

Erlotinib.

Steins M, Thomas M, Geissler M.

Recent Results Cancer Res. 2014;201:109-23. doi: 10.1007/978-3-642-54490-3_6. Review.

PMID:
24756788
39.

Phenobarbital induces cell cycle transcriptional responses in mouse liver humanized for constitutive androstane and pregnane x receptors.

Luisier R, Lempiäinen H, Scherbichler N, Braeuning A, Geissler M, Dubost V, Müller A, Scheer N, Chibout SD, Hara H, Picard F, Theil D, Couttet P, Vitobello A, Grenet O, Grasl-Kraupp B, Ellinger-Ziegelbauer H, Thomson JP, Meehan RR, Elcombe CR, Henderson CJ, Wolf CR, Schwarz M, Moulin P, Terranova R, Moggs JG.

Toxicol Sci. 2014 Jun;139(2):501-11. doi: 10.1093/toxsci/kfu038. Epub 2014 Apr 1.

PMID:
24690595
40.

Nab-paclitaxel for metastatic pancreatic cancer: clinical outcomes and potential mechanisms of action.

Al-Batran SE, Geissler M, Seufferlein T, Oettle H.

Oncol Res Treat. 2014;37(3):128-34. doi: 10.1159/000358890. Epub 2014 Feb 7. Review.

41.

[S3-guideline exocrine pancreatic cancer].

Seufferlein T, Porzner M, Becker T, Budach V, Ceyhan G, Esposito I, Fietkau R, Follmann M, Friess H, Galle P, Geissler M, Glanemann M, Gress T, Heinemann V, Hohenberger W, Hopt U, Izbicki J, Klar E, Kleeff J, Kopp I, Kullmann F, Langer T, Langrehr J, Lerch M, Löhr M, Lüttges J, Lutz M, Mayerle J, Michl P, Möller P, Molls M, Münter M, Nothacker M, Oettle H, Post S, Reinacher-Schick A, Röcken C, Roeb E, Saeger H, Schmid R, Schmiegel W, Schoenberg M, Siveke J, Stuschke M, Tannapfel A, Uhl W, Unverzagt S, van Oorschot B, Vashist Y, Werner J, Yekebas E; Guidelines Programme Oncology AWMF; German Cancer Society eV; German Cancer Aid.

Z Gastroenterol. 2013 Dec;51(12):1395-440. doi: 10.1055/s-0033-1356220. Epub 2013 Dec 11. German. No abstract available.

42.

[Diagnosis of and therapy for hepatocellular carcinoma].

Greten TF, Malek NP, Schmidt S, Arends J, Bartenstein P, Bechstein W, Bernatik T, Bitzer M, Chavan A, Dollinger M, Domagk D, Drognitz O, Düx M, Farkas S, Folprecht G, Galle P, Geißler M, Gerken G, Habermehl D, Helmberger T, Herfarth K, Hoffmann RT, Holtmann M, Huppert P, Jakobs T, Keller M, Klempnauer J, Kolligs F, Körber J, Lang H, Lehner F, Lordick F, Lubienski A, Manns MP, Mahnken A, Möhler M, Mönch C, Neuhaus P, Niederau C, Ocker M, Otto G, Pereira P, Pott G, Riemer J, Ringe K, Ritterbusch U, Rummeny E, Schirmacher P, Schlitt HJ, Schlottmann K, Schmitz V, Schuler A, Schulze-Bergkamen H, von Schweinitz D, Seehofer D, Sitter H, Straßburg CP, Stroszczynski C, Strobel D, Tannapfel A, Trojan J, van Thiel I, Vogel A, Wacker F, Wedemeyer H, Wege H, Weinmann A, Wittekind C, Wörmann B, Zech CJ.

Z Gastroenterol. 2013 Nov;51(11):1269-326. doi: 10.1055/s-0033-1355841. Epub 2013 Nov 15. German.

43.

Docetaxel, oxaliplatin and capecitabine (TEX regimen) in patients with metastatic gastric or gastro-esophageal cancer: results of a multicenter phase I/II study.

Stein A, Arnold D, Thuss-Patience PC, Moehler M, Grothe W, Seufferlein T, Reinacher-Schick A, Geissler M, Hofheinz RD, Schmoll HJ.

Acta Oncol. 2014 Mar;53(3):392-8. doi: 10.3109/0284186X.2013.833346. Epub 2013 Sep 12.

PMID:
24024696
44.

Safety and efficacy of RNAi therapy for transthyretin amyloidosis.

Coelho T, Adams D, Silva A, Lozeron P, Hawkins PN, Mant T, Perez J, Chiesa J, Warrington S, Tranter E, Munisamy M, Falzone R, Harrop J, Cehelsky J, Bettencourt BR, Geissler M, Butler JS, Sehgal A, Meyers RE, Chen Q, Borland T, Hutabarat RM, Clausen VA, Alvarez R, Fitzgerald K, Gamba-Vitalo C, Nochur SV, Vaishnaw AK, Sah DW, Gollob JA, Suhr OB.

N Engl J Med. 2013 Aug 29;369(9):819-29. doi: 10.1056/NEJMoa1208760.

45.

Assessment of multidrug resistance on cell coculture patterns using scanning electrochemical microscopy.

Kuss S, Polcari D, Geissler M, Brassard D, Mauzeroll J.

Proc Natl Acad Sci U S A. 2013 Jun 4;110(23):9249-54. doi: 10.1073/pnas.1214809110. Epub 2013 May 17.

46.

Shock-front injector for high-quality laser-plasma acceleration.

Buck A, Wenz J, Xu J, Khrennikov K, Schmid K, Heigoldt M, Mikhailova JM, Geissler M, Shen B, Krausz F, Karsch S, Veisz L.

Phys Rev Lett. 2013 May 3;110(18):185006. Epub 2013 May 2.

PMID:
23683211
47.

Primary hippocampal neurons, which lack four crucial extracellular matrix molecules, display abnormalities of synaptic structure and function and severe deficits in perineuronal net formation.

Geissler M, Gottschling C, Aguado A, Rauch U, Wetzel CH, Hatt H, Faissner A.

J Neurosci. 2013 May 1;33(18):7742-55. doi: 10.1523/JNEUROSCI.3275-12.2013.

48.

Capecitabine/irinotecan or capecitabine/oxaliplatin in combination with bevacizumab is effective and safe as first-line therapy for metastatic colorectal cancer: a randomized phase II study of the AIO colorectal study group.

Schmiegel W, Reinacher-Schick A, Arnold D, Kubicka S, Freier W, Dietrich G, Geißler M, Hegewisch-Becker S, Tannapfel A, Pohl M, Hinke A, Schmoll HJ, Graeven U.

Ann Oncol. 2013 Jun;24(6):1580-7. doi: 10.1093/annonc/mdt028. Epub 2013 Mar 4.

PMID:
23463625
49.

Thermo-active elastomer composite for optical heating in microfluidic systems.

Geissler M, Voisin B, Clime L, Le Drogoff B, Veres T.

Small. 2013 Mar 11;9(5):654-9. doi: 10.1002/smll.201202151.

PMID:
23456791
50.

Ion acceleration in multispecies targets driven by intense laser radiation pressure.

Kar S, Kakolee KF, Qiao B, Macchi A, Cerchez M, Doria D, Geissler M, McKenna P, Neely D, Osterholz J, Prasad R, Quinn K, Ramakrishna B, Sarri G, Willi O, Yuan XY, Zepf M, Borghesi M.

Phys Rev Lett. 2012 Nov 2;109(18):185006. Epub 2012 Nov 2.

PMID:
23215290

Supplemental Content

Loading ...
Support Center